HIMSS 2025: Peerbridge Health Unveils Cor MDx IoT ECG Wearable

Peerbridge Health kicked off the HIMSS Global Health Conference today by introducing Cor MDx, reportedly the world’s most powerful cardiac IoT wearable.

Touted as the next generation of remote cardiac monitoring, COR MDx represents a complete reimagining of traditional ECG wearable patches, according to the company. The device combines best-in-class signal fidelity and real-time multi-lead streaming and connectivity over BLE and LTE to offer a seamless, cost-effective solution for cardiac care. This step forward in technology delivers non-invasive cardiovascular and cardiopulmonary measurements to enable the 30+ indications previously announced in Peerbridge’s COR-INSIGHT trial.

Using Advanced AI to Bridge Gaps in Cardiac Care

With an estimated 40 million Americans suffering from undiagnosed heart failure and 85% of rural counties lacking a cardiologist, Cor MDx is designed to expand access to early detection and intervention for those in need but being missed today. The wearable will support full-spectrum monitoring, from 14-day Holter monitoring and mobile cardiac telemetry (MCT) to advanced hemodynamic assessments and acute care telemetry.

“Cor MDx sets a new benchmark in remote cardiac diagnostics and monitoring,” Peerbridge Health Ceo Chris Darland said. “This device not only enhances diagnostic yield but also dramatically reduces costs, enabling hospitals, physicians, and patients to access critical cardiac insights like never before. Our ongoing collaboration with AT&T further strengthens our ability to deliver seamless real-time connectivity, ensuring continuous cardiac monitoring for patients everywhere and the providers caring for them.”

AT&T provides the IoT backbone for Cor MDx, enabling real-time data transmission, remote study reconfiguration, and seamless management over LTE, for optimal patient monitoring.

“AT&T is helping Peerbridge through secure, intelligent connectivity,” said David Garver, area vice president, AT&T Connected Solutions. “We support Peerbridge Health’s Cor MDx wearable with wireless connectivity so they can deliver AI-powered, hospital-grade cardiac diagnostics and monitoring. Peerbridge’s technology enables predictive, personalized care to help enhance the quality of care for patients.”

Cor MDx is expected to launch commercially in the second half of 2025, pending regulatory approvals.

The device will initially be deployed in the COR-INSIGHT clinical trials involving up to 15,000 participants at hospitals, outpatient clinics, and medical research centers. Hospital systems participating in the HeartX program, led by HealthTech Arkansas and MedAxiom, will have first access to the Cor MDx device as the teams work together to deliver improved outcomes to rural U.S. patients.

“In our view, reaching underserved communities means bringing hospital-grade tools directly to their doorsteps in the most inexpensive way imaginable. Achieving this goal required a complete re-tooling of the hardware, software and cost structure for Peerbridge Health,” Darland added. “We’re fortunate to have AT&T supporting our mission of delivering ultra low-cost cardiac diagnostics and monitoring to millions of patients falling between the cracks today.”

Peerbridge Health claims to be the first company to bring the quality and accuracy of hospital-grade cardiac diagnostics and monitoring to the home. The company’s artificial intelligence-enabled device, Peerbridge Cor, includes a three-lead, patented AECG wearable device that features a design based on the Einthoven Triangle. The Peerbridge platform leverages ECG to diagnose and monitor the most important elements of cardiac care at a lower cost than ever before. Data captured provides actionable insights that promote early invention, reduce hospital visits, and saves lives.